Gemini GP Ltd has submitted a 13F Notice, detailing its investment holdings as of September 30, 2026. This filing is significant as it provides insights into the company's financial strategy and portfolio adjustments.

Gemini GP Ltd, identified by CIK 0001965251, operates within the financial sector. The company's recent filings include a 13F Notice dated November 13, 2026, and several other filings throughout 2026, including N-PX forms and additional 13F Notices.

The latest filing indicates that Gemini GP Ltd is actively managing its investment portfolio. The filing states, "report type: 13F NOTICE" and lists the period of report as September 30, 2026.

This update may affect various stakeholders, including investors who track the company's investment strategies and other firms within the financial industry that may be influenced by Gemini's actions.

The filing does not say what happens next.

Filing Details

The filing was submitted under the SEC Act of 1934 and is categorized as a 13F-NT, indicating it is a notice of the company's investment holdings. The filing number associated with this submission is 028-22983, and it was filed as of November 13, 2026, for the reporting period ending September 30, 2026.

Company Information

Gemini GP Ltd is based in Washington, DC, with its business address listed as c/o Goodwin Procter LLP, 1900 N Street, NW, Washington, DC 20036. The company is represented by David Muir, who serves as President, and can be contacted at the phone number 646-964-5790.

Other Managers

The filing also mentions another manager, Orland Properties Ltd, which has its own filing number (028-18610). This indicates that Gemini GP Ltd may be collaborating or coordinating with other investment managers in its portfolio management strategy.

This filing highlights the continued engagement of Gemini GP Ltd in the investment landscape, reflecting its commitment to transparency and regulatory compliance.